Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla Gearing

Showing results (111-120 of 190) with videos related to

Pageof 19
Sort By:
Acta Neuropathologica Communications|February 19, 2016
CSF complement 3 and factor H are staging biomarkers in Alzheimer's diseaseWilliam T Hu, Kelly D Watts, Prashant Tailor, et al.
Neuroscience Letters|May 29, 2012
Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brainElaine L Pranski, Carson D Van Sanford, Nirjari V Dalal, et al.
The American Journal of Pathology|May 27, 2004
alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion diseaseNigel J Cairns, Victoria Zhukareva, Kunihiro Uryu, et al.
Acta Neuropathologica|June 2, 2004
alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseasesNigel J Cairns, Kunihiro Uryu, Eileen H Bigio, et al.
Neurobiology of Disease|September 22, 2020
Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273RAlexander Sandberg, Helen Ling, Marla Gearing, et al.
Human Molecular Genetics|April 10, 2016
5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicityAlison I Bernstein, Yunting Lin, R Craig Street, et al.
Neurobiology of Disease|March 3, 2009
A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's diseasePier Giorgio Mastroberardino, Eric K Hoffman, Maxx P Horowitz, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
pTDP-43 levels correlate with cell type specific molecular alterations in the prefrontal cortex of <i>C9orf72</i> ALS/FTD patientsHsiao-Lin V Wang, Jian-Feng Xiang, Chenyang Yuan, et al.
Annals of Clinical and Translational Neurology|December 26, 2014
Analysis of graft survival in a trial of stem cell transplant in ALSTezeta Tadesse, Marla Gearing, David Senitzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2025
pTDP-43 levels correlate with cell type-specific molecular alterations in the prefrontal cortex of <i>C9orf72</i> ALS/FTD patientsHsiao-Lin V Wang, Jian-Feng Xiang, Chenyang Yuan, et al.
Pageof 19

Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
Acta Neuropathologica Communications|February 19, 2016
CSF complement 3 and factor H are staging biomarkers in Alzheimer's diseaseWilliam T Hu, Kelly D Watts, Prashant Tailor, et al.
Neuroscience Letters|May 29, 2012
Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brainElaine L Pranski, Carson D Van Sanford, Nirjari V Dalal, et al.
The American Journal of Pathology|May 27, 2004
alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion diseaseNigel J Cairns, Victoria Zhukareva, Kunihiro Uryu, et al.
Acta Neuropathologica|June 2, 2004
alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseasesNigel J Cairns, Kunihiro Uryu, Eileen H Bigio, et al.
Neurobiology of Disease|September 22, 2020
Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273RAlexander Sandberg, Helen Ling, Marla Gearing, et al.
Human Molecular Genetics|April 10, 2016
5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicityAlison I Bernstein, Yunting Lin, R Craig Street, et al.
Neurobiology of Disease|March 3, 2009
A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's diseasePier Giorgio Mastroberardino, Eric K Hoffman, Maxx P Horowitz, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
pTDP-43 levels correlate with cell type specific molecular alterations in the prefrontal cortex of <i>C9orf72</i> ALS/FTD patientsHsiao-Lin V Wang, Jian-Feng Xiang, Chenyang Yuan, et al.
Annals of Clinical and Translational Neurology|December 26, 2014
Analysis of graft survival in a trial of stem cell transplant in ALSTezeta Tadesse, Marla Gearing, David Senitzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2025
pTDP-43 levels correlate with cell type-specific molecular alterations in the prefrontal cortex of <i>C9orf72</i> ALS/FTD patientsHsiao-Lin V Wang, Jian-Feng Xiang, Chenyang Yuan, et al.
Pageof 19